Clinical Trials Browser

Locally Advanced Pancreatic Adenocarcinoma × spartalizumab × Clear all

NCT05607953 2025-07-04

Pressure Enabled Intrapancreatic Delivery of SD-101 With Checkpoint Blockade for Locally Advanced Pancreatic Adenocarcinoma

Phase 1 Active not recruiting

Gastrointestinal

Locally Advanced Pancreatic Adenocarcinoma